ARTICLE | Clinical News
Activated cellular therapy (ACT): Completed Phase I testing enrollment
March 10, 1999 8:00 AM UTC
Neoprobe Corp. (NEOP), Dublin, Ohio Product: Activated cellular therapy (ACT), derived from RIGS technology Indication: AIDS Status: NEOP announced completion of enrollment in Phase I testing. A total...